We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

73 hedge funds and large institutions have $147M invested in abrdn Life Sciences Investors in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 20 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 20

4% more capital invested

Capital invested by funds: $142M → $147M (+$5.63M)

1.25% less ownership

Funds ownership: 31.69% → 30.44% (-1.3%)

12% less funds holding

Funds holding: 83 → 73 (-10)

42% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 19

Holders
73
Holders Change
-10
Holders Change %
-12.05%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
28
Reduced
20
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$4.94M
2
Raymond James Financial
Raymond James Financial
Florida
+$2.92M
3
PCM
Penserra Capital Management
California
+$1.36M
4
LPL Financial
LPL Financial
California
+$1.26M
5
LCM
Landscape Capital Management
New Jersey
+$1.16M

Top Sellers

1
SCM
Saba Capital Management
New York
-$7.89M
2
KIM
Karpus Investment Management
New York
-$4.66M
3
WAM
Wolverine Asset Management
Illinois
-$1.99M
4
RCM
Rivernorth Capital Management
Florida
-$1.83M
5
TJHA
Thomas J. Herzfeld Advisors
Florida
-$1.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Saba Capital Management
New York
$35.5M -$7.89M -469,478 -18%
Morgan Stanley
2
Morgan Stanley
New York
$19.5M +$4.94M +294,168 +34%
PCM
3
Penserra Capital Management
California
$14.7M +$1.36M +80,988 +10%
Raymond James Financial
4
Raymond James Financial
Florida
$10M +$2.92M +174,024 +41%
LPL Financial
5
LPL Financial
California
$7.53M +$1.26M +74,787 +20%
NIM
6
Needham Investment Management
New York
$6.77M – – –
FHA
7
Flagship Harbor Advisors
Massachusetts
$6.1M +$105K +6,257 +2%
Allspring Global Investments
8
Allspring Global Investments
North Carolina
$3.87M -$85.1K -5,062 -2%
RCM
9
Rivernorth Capital Management
Florida
$3.33M -$1.83M -108,907 -35%
Ameriprise
10
Ameriprise
Minnesota
$3.2M -$320K -19,033 -9%
AAM
11
Advisors Asset Management
Colorado
$2.82M +$154K +9,178 +6%
1WA
12
180 Wealth Advisors
Washington
$2.59M +$85.1K +5,067 +3%
SFS
13
Shaker Financial Services
Virginia
$1.94M -$1.38M -82,385 -42%
1CP
14
1607 Capital Partners
Virginia
$1.93M -$119K -7,100 -6%
FAM
15
Formidable Asset Management
Ohio
$1.93M +$811K +48,252 +63%
Bank of America
16
Bank of America
North Carolina
$1.79M -$110K -6,566 -6%
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$1.75M +$417K +24,843 +31%
WIA
18
World Investment Advisors
California
$1.67M +$112K +6,654 +7%
WAM
19
Wolverine Asset Management
Illinois
$1.63M -$1.99M -118,399 -55%
Janney Montgomery Scott
20
Janney Montgomery Scott
Pennsylvania
$1.47M +$92.6K +5,508 +7%
BBPWM
21
Blue Bell Private Wealth Management
Pennsylvania
$1.29M +$206K +12,242 +19%
UPS
22
UHLMANN PRICE SECURITIES
Illinois
$1.28M +$37.6K +2,238 +3%
LCM
23
Landscape Capital Management
New Jersey
$1.16M +$1.16M +69,030 New
ZCP
24
Z3 Capital Partners
Virginia
$1.12M +$1.12M +66,849 New
PAG
25
Private Advisor Group
New Jersey
$1.08M +$9.06K +539 +0.8%
1
2 3 4

HQL Hedge Fund Activity: Q4 2025 in Review

73 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q4 2025, worth a combined $147M — up 4% from $142M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of HQL and 11 opened new positions — a net loss of 8 holders — while 20 trimmed existing stakes and 28 added.

The largest buyer was Morgan Stanley, adding an estimated $4.94M. The largest seller was Saba Capital Management, cutting an estimated $7.89M.

  • 73 institutional investors held abrdn Life Sciences Investors (HQL) as of Q4 2025, down from 83 in Q3 2025.
  • Funds reported $147M of abrdn Life Sciences Investors stock for Q4 2025, up 4% quarter-over-quarter.
  • 11 funds opened new abrdn Life Sciences Investors positions in Q4 2025 and 19 closed out, a net change of -8 holders.
  • The largest abrdn Life Sciences Investors buyer in Q4 2025 was Morgan Stanley, an estimated $4.94M added.
  • The largest abrdn Life Sciences Investors seller in Q4 2025 was Saba Capital Management, an estimated $7.89M sold.

Based on aggregated 13F filings for Q4 2025.